(858) 412-4156

site-logo
  • About
    • Company
    • Technology
    • Business Development
    • Contact
  • Advisor
    • Scientific Advisory Board
  • Pipeline
    • Full Pipeline
    • RBC Nanosponge
      • MRSA Pneumonia
      • MRSA Vaccine
      • Diabetic Foot Ulcer
    • Macrophage Nanosponge
      • Sepsis
      • Cytokine Release Syndrome (CRS)
      • COVID-19
      • Inflammatory Bowel Disease
      • Arthritis
  • News
  • Career
  • Contact
featured-generic.jpg

Cellics Therapeutics Receives First IND Allowance by FDA for its Innovative Cellular Nanoparticle (CNP) Technology

May 3, 2022

(San Diego) May 3 rd , 2022 – Cellics Therapeutics, Inc., a biotech startup company using the innovative Cellular Nanoparticle (CNP) Technology for the treatment and prevention of infectious and inflammatory diseases, announced today that…

[Read More]

Category: Company News

Cellics Announces the Receipt of CARB-X Award of Up to US$15 Million

October 24, 2020

San Diego, CA (October 21st) – Cellics announced today that it has received a CARB-X Award of up to US$15 Million to develop a new treatment for sepsis caused by drug-resistant Gram-positive and Gram-negative bacteria….

[Read More]

Category: Awards and Recognition

Cellics Therapeutics Announces the Publication of Cellular Nanosponges Inhibit SARS-CoV-2 Infectivity in Nano Letters

June 17, 2020

SAN DIEGO, (June 17, 2020, Globe Newswire) — Cellics Therapeutics, Inc. (Cellics) announced today that results of the study that evaluates the potential benefits of macrophage and pulmonary epithelial nanosponges in neutralizing SARS-CoV-2 infectivity have…

[Read More]

Category: Company News

Our Mission

Cellics is committed to saving lives and improving patients’ health using innovative biomimetic nanomedicines. We strive to develop more effective and safer therapeutics and vaccines for diseases and unmet medical needs.

Our Info

11588 Sorrento Valley Rd.
Suite #20
San Diego, CA 92121

(858) 412-4156

info@cellics.com


Locate Us

Copyright 2022 © Cellics Therapeutics All rights reserved. Privacy Policy Developed by TinyFrog Technologies